Skip to content

CONEXUS PHARMA

Absorbed by REGON on 30-01-2018 KBO/BCE: BE 0538.611.801 subsidiary of REGON

Lifetime

3 annual accounts with figures on one time axis
peak of -€2,889 in 2014
-€8,139▲ €22,553
lowest -€36,198 in 2015
-€1,839▲ €34,359
peak of €52,797 in 2014
€14,759▼ 11.1%
€958▼ 89.4%
Board5 names since 2013
- 
Documentsfilings and deeds
01-08-20171 day late
2016micro format
Gross margin from -€30,691 to -€8,139Loss of €1,839Debts from €9,054 to €958Cash from €9,297 to €15,034

Key points

from the 2016 annual accounts, the last ones filed

Losses

-€46,741 in three years
-8,7032014-36,1982015-1,8392016

Every financial year from 2014 to 2016 closed with a loss. 2015 was the heaviest.

Liquidity

15.69 was 1.18 in 2015

Short-term debts fell from €9,054 to €958.

Filings

3 annual accounts 2 late
AprilJune31 JulyOctober201420152016

The 2014 accounts came in latest, 4 days after the end of the period.

Turnover not published in the abbreviated or micro format

Board and ownership

last known board
Director, last mentioned in 2014
Director, last mentioned in 2014
Director, last mentioned in 2014
Director, last mentioned in 2014
  • 100%equity €2.5m (2025) · deed of 15-09-2017
Board & ownership

Recent changes

Merger: absorbed by REGON Dissolution of the company · Dissolved without liquidation · Books and records kept by REGON · General meeting of 23-10-2017 · Gazette deed
Merger proposal: to be absorbed by Bvba Regon and act as permanent representatives · Bvba Regon holds all the shares · Gazette deed
4 directors appointed (managing director), , REGON and · and act as permanent representatives · Gazette deed
Incorporation Founded by , , REGON and 2 others · Founding capital of €61,500, 10,000 shares · (managing director), , REGON and appointed · Gazette deed
All 9 events

Official details

Source: KBO
Status
Absorbed by REGONmerger by absorption, January 2018
Activity
“1°Het uitvoeren van alle vormen van onderzoek en ontwikkeling op biologische producten,chemische producten,farmaceutische producten,cosmeticaproducten,dieetvoeding…” (deed in Dutch)From the articles, 6 activitiesNo NACE code in the KBO
Financial year end
31 December
Peppol
Not found in the Peppol Directory
Company details

Annual accounts 2016

€15,718▼ 38.7%
Filing
Filed on 01-08-2017
Financials

Insights on CONEXUS PHARMA

Absorbed by REGON in January 2018. The last annual accounts are for financial year 2016. The company was dissolved without liquidation. The books and records are kept by REGON.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about CONEXUS PHARMA

What is the company number of CONEXUS PHARMA?
The company number of CONEXUS PHARMA is 0538.611.801. The VAT number is the same number with BE in front: BE 0538.611.801.
What is the legal form of CONEXUS PHARMA?
Legal form of CONEXUS PHARMA: NV.
Is CONEXUS PHARMA still active?
No. Absorbed in a merger on 30-01-2018.Company details
What is the turnover of CONEXUS PHARMA?
The annual accounts for financial year 2016 state no turnover. The abbreviated or micro format does not require it.Financials
Is CONEXUS PHARMA profitable?
In financial year 2016, CONEXUS PHARMA made a loss of €1,839.
Where can I find the annual accounts of CONEXUS PHARMA?
CONEXUS PHARMA filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2016.

Next steps

Keep this company with today's facts in a case file.